The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated results on the bispecific PSMAxCD3 antibody CC-1 for treatment of prostate cancer.
 
Jonas S. Heitmann
Employment - BiconY Therapeutics
Travel, Accommodations, Expenses - Synimmune
 
Christopher Hackenbruch
No Relationships to Disclose
 
Juliane S. Walz
Stock and Other Ownership Interests - ViferaXS
Consulting or Advisory Role - OrganoidScience; SwarmOncology
Research Funding - Roche
Patents, Royalties, Other Intellectual Property - Inventor on a patent on the peptides mentioned in the abstract
 
Susanne Jung
No Relationships to Disclose
 
Martin Pflügler
Employment - BiconY Therapeutics
Leadership - BiconY Therapeutics; TWYCE GmbH
Patents, Royalties, Other Intellectual Property - patent of antibody
 
Richard F. Schlenk
Consulting or Advisory Role - , Pfizer; Daiichi Sankyo
Speakers' Bureau - Daiichi Sankyo; Novartis; Pfizer
Research Funding - AstraZeneca; Daiichi Sankyo; Pfizer; PharmaMar; Recordati; Roche
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Sebastian Ochsenreither
Honoraria - AstraZeneca; BMS; immunocore; Janssen Oncology; Merck Serono; MSD
Consulting or Advisory Role - immunocore; Janssen-Cilag; MSD; Pfizer
Research Funding - Bayer (Inst)
Patents, Royalties, Other Intellectual Property - Cyclin A1 as T-cell target
Travel, Accommodations, Expenses - Janssen Oncology; Merck Serono; Pfizer
 
Boris A. Hadaschik
Consulting or Advisory Role - ABX Advanced biochemical compounds; Accord Healthcare; Amgen; Astellas Pharma; Bayer; BMS GmbH & Co. KG; Ipsen; Janssen; Lightpoint medical; Merck KGaA; MSD; Novartis; Onkowissen; Pfizer; POINT Biopharma
Research Funding - Bristol Myers Squibb (Inst); Janssen; Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Uromed
Travel, Accommodations, Expenses - AstraZeneca; Bayer; BMS; Ipsen; Janssen
 
Christopher Darr
Honoraria - Bayer; Ipsen; Janssen
Consulting or Advisory Role - Ipsen; Janssen
Research Funding - Deutsche Forschungsgemeinschaft (Inst)
Travel, Accommodations, Expenses - Bayer; Ipsen; Janssen
 
Gundram Jung
Employment - TWYCE GmbH
Consulting or Advisory Role - Allen & Overy LLP
Patents, Royalties, Other Intellectual Property - holder of patent
 
Helmut R. Salih
Stock and Other Ownership Interests - Immatics
Consulting or Advisory Role - Novartis; Pfizer; Philogen; Synimmune
Research Funding - ABL Bio
Patents, Royalties, Other Intellectual Property - Inventor on several patents in the field of caner immunotherapy
(OPTIONAL) Uncompensated Relationships - TWYCE GmbH